Article Sidebar

Submitted
20 August 2019
Accepted
26 July 2022
Published
5 September 2022
Download
pdf
Statistic
Read Counter : 382 Download : 249

Main Article Content

Abstract

Highlight:



  1. The diagnosis and therapy of Congenital Adrenal Hyperplasia (CAH) children with Adrenal crisis (AC) case report.

  2. Adrenal crisis (AC) is a life-threatening emergency that contributes to the high death rate of children with adrenal insufficiency.

  3. The early detection and prompt treatment can improve the outcomes of patients with CAH and AC.


 


Abstract:


Adrenal crisis is the acute complication of the patient with congenital adrenal hyperplasia. Congenital adrenal hyperplasia (CAH) is a rare condition. Children with CAH commonly come to the emergency room due to acute complications. The condition has high mortality and thus needs early recognition. Newborn screening for CAH in Indonesia is not routinely performed and has not been suggested yet. The purpose of this case report was to report a case of adrenal crisis in a congenital adrenal hyperplasia patient focused on diagnosis and therapy. A female, 10 months old infant, was admitted to the emergency department with a chief complaint of a decrease of consciousness for 3 hours before admission and frequent vomiting since born. On physical examination, there was clitoromegaly. Laboratory showed 17-OH progesterone: 173 ng/dL (7-77 ng/dL) and karyotyping: 46 XX. Management of adrenal crisis is a stress dose of hydrocortisone and rehydration. Education is the key to optimal outcomes and normal growth and development.

Keywords

46 XX Adrenal Crisis Congenital Adrenal Hyperplasia Management Human and health Food nutrition improvement

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite
Rochmah, N., Faizi, M., Kusumastuti, N. P., Samadhi, L. F. M., & Deakandi, W. Y. (2022). Diagnosis and Management of Adrenal Crisis in 46XX Congenital Adrenal Hyperplasia Infant. Folia Medica Indonesiana, 58(3), 273–279. https://doi.org/10.20473/fmi.v58i3.14891
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Ali S, Bryce J, Haghpanahan H, et al (2021). Real-world estimates of adrenal insufficiency-related adverse events in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 106, 192–203.
  2. Allolio B (2015). Extensive expertise in endocrinology - Adrenal crisis. Eur. J. Endocrinol. 172, 115–124.
  3. Arlt W, Allolio B (2003). Adrenal insufficiency. Lancet 361, 1881–1893.
  4. Ashrafuzzaman SM, Rahim MA (2015). Adrenal insufficiency. Bridem Med. J. 5, 43–48.
  5. Bancos I, Hahner S, Tomlinson J, et al (2015). Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 3, 216–226.
  6. Betterle C, Presotto F, Furmaniak J (2019). Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J. Endocrinol. Invest. 42, 1407–1433.
  7. Bogaert T, Vandevyver S, Dejager L, et al (2011). Tumor necrosis factor inhibits glucocorticoid receptor function in mice: A strong signal toward lethal shock. J. Biol. Chem. 286, 26555–26567.
  8. Bouillon R (2006). Acute adrenal insufficiency. Endocrinol. Metab. Clin. North Am. 35, 767–775.
  9. Bowden S, Henry R (2018). Pediatric adrenal insufficiency: Diagnosis, management, and new therapies. Int. J. Pediatr. 2018, 1–9.
  10. Charmandari E, Nicolaides N, Chrousos G (2014). Adrenal insufficiency. Lancet 383, 2152–2167.
  11. Grossman A, Johannsson G, Quinkler M, et al (2013). Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: Clinical insights from across Europe. Eur. J. Endocrinol. 169, 165–175.
  12. Hahner S, Spinnler C, Fassnacht M, et al (2015). High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: A prospective study. J. Clin. Endocrinol. Metab. 100, 407–416.
  13. Hubby H, Suharjono S, Djafar Z (2016). Potassium monitoring in heart failure patients receiving combined therapy of captopril and furosemide. Folia Medica Indones. 52, 285–289.
  14. Husebye E (2014). Consensus statement on the diagnosis, treatment, and follow-up of patients with primary adrenal insufficiency. J. Intern. Med. 275, 104–115.
  15. Ishii T, Adachi M, Takasawa K, et al (2018). Incidence and characteristics of adrenal crisis in children younger than 7 years with 21-hydroxylase deficiency: A nationwide survey in Japan. Horm. Res. Paediatr. 89, 166–171.
  16. Koniaris L, Wand G, Wright T (2001). TNF mediates a murine model of Addison’s crisis. Shock 15, 29–34.
  17. Krone N, Arlt W (2009). Genetics of congenital adrenal hyperplasia. Best Pract. Res. Clin. Endocrinol. Metab. 23, 181–192.
  18. Laitinen T, Lyyra-Laitinen T, Huopio H, et al (2008). Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann. Noninvasive Electrocardiol. 13, 97–105.
  19. Lentz S, Collier K, Wllis G, et al (2022). Diagnosis and management of adrenal insufficiency and adrenal crisis in the emergency department. J. Emerg. Med. 1–9.
  20. Lousada L, Mendonca B, Bachega T (2021). Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia. Arch. Endocrinol. Metab. 65, 488–494.
  21. Mallappa A, Merke D (2022). Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat. Rev. Endocrinol. 18, 337–352.
  22. Miller W, Flück C, Breault D, et al (2008). The adrenal cortex and its disorders. In: Sperling Pediatric Endocrinology (Third Edition). Elsevier Saunder Co., Philadelphia, pp. 444–511.
  23. Nisticò D, Bossini B, Benvenuto S, et al (2022). Pediatric adrenal insufficiency: Challenges and solutions. Ther. Clin. Risk Manag. 11, 47–60.
  24. Nowotny H, Ahmed S, Bensing S, et al (2021). Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine 71, 586–594.
  25. Parham W, Mehdirad A, Biermann K, et al (2006). Hyperkalemia revisited. Texas Hear. Inst. J. 33, 40–47.
  26. Puar T, Stikkelbroeck N, Smans L, et al (2016). Adrenal crisis: Still a deadly event in the 21st century. Am. J. Med. 129, 1–9.
  27. Reisch N, Willige M, Kohn D, et al (2012). Frequency and causes of adrenal crises over a lifetime in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167, 35–42.
  28. Robinson R, Harris N, Ireland R, et al (2003). Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 52, 1469–1474.
  29. Rushworth R, Torpy D (2014). A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC Endocr. Disord. 14, 1–8.
  30. Sapolsky R, Romero L, Munck A (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21, 55–89.
  31. Shepherd L, Schmidtke K, Hazlehurst J, et al (2022). Interventions for the prevention of adrenal crisis in adults with primary adrenal insufficiency: A systematic review. Eur. J. Endocrinol. 187, 1–20.
  32. Silverman M, Pearce B, Biron C, et al (2005). Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 18, 41–78.
  33. Speiser P, Arlt W, Auchus R, et al (2018). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103, 4043–4088.
  34. Ten S, New M, Maclaren N (2001). Clinical review 130: Addison’s disease 2001. J. Clin. Endocrinol. Metab. 86, 2909–2922.
  35. Ucar A, Bas F, Saka N (2016). Diagnosis and management of pediatric adrenal insufficiency. World J. Pediatr. 12, 261–274.
  36. Verbalis J, Goldsmith S, Greenberg A, et al (2013). Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations. Am. J. Med. 126, 1–42.
  37. Webb E, Krone N (2015). Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Best Pract. Res. Clin. Endocrinol. Metab. 29, 449–468.
  38. Webster J (2001). Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance. In: Proceedings of the National Academy of Sciences of the United States of America. pp. 6865–6870.